5E1S | date | |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | |||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | |||||||||||||
ligand | 5JA | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | BI 885578, a novel IGF1R/INSR tyrosine kinase inhibitor with pharmacokinetic properties that dissociate anti-tumor efficacy and perturbation of glucose homeostasis., Sanderson MP, Apgar J, Garin-Chesa P, Hofmann MH, Kessler D, Quant J, Savchenko A, Schaaf O, Treu M, Tye H, Zahn SK, Zoephel A, Haaksma E, Adolf GR, Kraut N, Mol Cancer Ther. 2015 Oct 5. pii: molcanther.0539.2015. PMID:26438154 |
Data retrieval |
View 5E1S in 3D |
Visual 3D analysis of 5E1S |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5E1S |
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |